ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EDAP EDAP TMS SA

5.20
0.215 (4.31%)
Last Updated: 16:02:32
Delayed by 15 minutes
Share Name Share Symbol Market Type
EDAP TMS SA NASDAQ:EDAP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.215 4.31% 5.20 5.12 5.20 5.20 5.00 5.108 1,144 16:02:32

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action against EDAP TMS S.A. & Its Board of Directors & a...

29/09/2014 11:33pm

Business Wire


EDAP TMS (NASDAQ:EDAP)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more EDAP TMS Charts.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased EDAP TMS S.A. (“EDAP” or the “Company”) (NasdaqGM:EDAP) common stock between February 1, 2013 and July 30, 2014.

For more information, click here: http://zlk.9nl.com/edap-tms-edap.

The complaint alleges that during the Class Period the Company made false and/or misleading statements regarding its Ablatherm-HIFU device. In particular it is alleged that the Company made false and/or misleading statements and/or failed to disclose that: (a) the Company overstated the efficacy and safety of its Ablatherm trials by relying on cross-study comparisons rather than a head-to-head trial; (b) the study’s survival endpoint was inappropriate for the patient populations; and (c) as a result of the aforementioned, the Company’s statements regarding its business and operations were materially false and misleading at all relevant times.

On July 30, 2014, the FDA announced that a panel found EDAP had failed to demonstrate the efficacy of its product or that the benefits of the device outweighed its risks.

If you suffered a loss in EDAP you have until October 3, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/edap-tms-edap.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky, Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax: 866-367-6510www.zlk.com

1 Year EDAP TMS Chart

1 Year EDAP TMS Chart

1 Month EDAP TMS Chart

1 Month EDAP TMS Chart